ONWARD Medical's ARC-EX System Recognized
ONWARD Medical N.V. has garnered significant attention with its ARC-EX System being acknowledged as one of TIME's Best Inventions. This medical technology firm, engaged in developing groundbreaking therapies aimed at restoring movement, function, and independence for individuals grappling with spinal cord injuries (SCI), has truly made its mark. This accolade spotlights the potential of the ARC-EX System to benefit countless individuals suffering from the effects of SCI.
CEO Insights on the Recognition
In a statement, CEO Dave Marver expressed heartfelt gratitude for the recognition bestowed by TIME, highlighting the system's promise of transforming the lives of those affected by SCI and related challenges. He noted, "SCI is a devastating injury that can change lives in an instant. We are hopeful that the ARC-EX Therapy is just the first of many innovative therapies we can introduce for the benefit of the Spinal Cord Injury Community." This acknowledgment emphasizes the impact such technologies can have on enhancing the quality of life.
The Selection Process Explained
TIME's annual roundup of innovations reflects the influence of remarkable advancements that change lives, encompassing 200 diverse entries this year. The rigorous selection process involved nominations from TIME's editorial team and global correspondents, carefully evaluating each candidate based on originality, efficacy, ambition, and real-world impact, particularly in vibrant sectors including healthcare, AI, and renewable energy.
Understanding the Significance of ARC-EX Therapy
The timing of this acknowledgment is poignant, coinciding with the release of the feature film "Super/Man: The Christopher Reeve Story," which sheds light on the hurdles faced by individuals with SCI. Chet Moritz, PhD, a professor in Rehabilitation Medicine, emphasized the hope that the ARC-EX System brings, capable of assisting individuals in performing everyday tasks, such as using a toothbrush, holding a cup, and hugging loved ones. He reflected on heartwarming stories of those who, post-therapy, have reclaimed skills such as playing the guitar or painting, leading to greater independence.
Clinical Findings and Regulatory Pursuits
This accolade for the ARC-EX System follows the publication of promising findings from the Up-LIFT pivotal trial in a prestigious medical journal. Results indicated notable enhancements in upper limb strength and function among participants with SCI, showcasing the system's potential to improve life quality significantly. In anticipation of further advancements, ONWARD Medical is preparing applications for regulatory approval in the US, aiming to launch the ARC-EX Therapy shortly, contingent upon successful regulatory outcomes.
Global Impact of Spinal Cord Injury
Globally, about seven million people grapple with the consequences of SCI, while the United States alone accounts for nearly 300,000 individuals living with such injuries. For these people, regaining arm and hand functions remains a primary concern, as indicated by surveys where over 75% identified it as their top priority for recovery. Moreover, insights from the Up-LIFT trial revealed that 90% of participants noted improvements in strength or functionality, translating into an enhanced overall quality of life.
ONWARD Medical's Vision for the Future
ONWARD Medical, committed to developing novel solutions for movement restoration following SCI, underpins its innovations through a decade's worth of dedicated scientific inquiry, field research, and clinical studies. The company's ARC Therapy, delivered via the ARC-EX and ARC-IM platforms, is poised to revolutionize treatment options for individuals facing movement disabilities. With plans underway for the ARC-BCI platform deployment, ONWARD is dedicated to advancing technologies to facilitate thought-driven movement restoration.
Expanding Horizons in Clinical Research
ONWARD Medical continues its forward momentum by conducting ongoing clinical studies centered around enhancing mobility in individuals with SCI and addressing challenges faced by those with Parkinson's disease. The company also focuses on its ARC-IM Therapy, which has demonstrated encouraging clinical outcomes in regulating blood pressure within this patient group, further solidifying its role in the brain-computer interface (BCI) space.
Company's Global Reach and Contact
Based in Eindhoven, ONWARD Medical also maintains a Science and Engineering Center in Lausanne and an office in Boston. The company trades as ONWD on the Euronext markets in Paris, Brussels, and Amsterdam, showcasing its global operational footprint.
Frequently Asked Questions
What is the ARC-EX System?
The ARC-EX System is an innovative therapeutic technology developed by ONWARD Medical aimed at restoring movement and function for individuals with spinal cord injuries.
Why was the ARC-EX System recognized by TIME?
TIME recognized the ARC-EX System for its potential to significantly change the lives of individuals suffering from spinal cord injuries and improve quality of life overall.
What clinical results support the ARC-EX System's effectiveness?
Results from the Up-LIFT pivotal trial showed significant improvements in upper limb strength and function among participants, with 90% reporting enhanced abilities.
Where can I find more information about ONWARD Medical?
For additional details on ONWARD Medical and its therapies, please visit ONWD.com.
How does ONWARD Medical support the spinal cord injury community?
ONWARD Medical partners with the SCI community to develop innovative solutions that restore movement, function, and independence for those affected by spinal cord injuries.
